WELCOME TO WADA CLINIC

WELCOME TO WADA CLINIC 

 A Registered Non Hospital Residential  Substance Use Disorder and Mental Health Care Facility

                      

A Registered Non Hospital  Residential facility providing comprehensive mental health and addiction treatment services in  Rawalpindi.

it is first rehabilitation facility at Pakistan where international certified addiction professional provide their services with collaboration of Psychiatric Pharmacist.No other rehab facility have had the facility of Psychiatric Pharmacist.

Our Islamabad Branch:Due to unavailability of building our Islamabad branch is shifted to House NO. E-49/5,E-Block,Sattelite Town in front of Gate No.1,Holy family Hospital,Rawalpindi

Be aware currently we do not have any branch at Islamabad.  

Head Office Branch:- House No. E-49/5,E-Block,Sattelite Town in front of Gate No.1,Holy Family Hospital, Rawalpindi

Ph:- +92-51-4801499

24/7 Cell :- +92-333-5433822.

               wada4life@gmail.com 

Rawalpindi                                 
051-4801499  
0333-5433822                              

The United Nations Office on Drug and Crime presented its annual drug report recently, which says that Pakistan’s annual heroin market is worth $1.2 billion. With more than 90 per cent of the world’s opium being produced in neighbouring Afghanistan, Pakistan becomes the main route for opium to be supplied to the world. According to government sources, 600,000 people enter into drug abuse in Pakistan annually. 
To give a short history of heroin use in Pakistan, this menace came into prominence in the wake of the Soviet invasion of Afghanistan. Domestic cultivation of poppy in Pakistan started to decline from the 90s, from a peak level of 9,4441 hectares in 1992 to a ‘poppy-free’ status in 2000, but since 2003, the cultivation has again picked up pace. The problematic areas are concentrated in FATA, and concerns about losing community acquiescence in the counter-terrorism operations coupled with a lack of security forces, are crucial factors hampering eradication efforts.

"After five years of the U.S. occupation, Afghanistan's drug production had swelled to unprecedented proportions. In August 2007, the U.N. reported that the country's record opium crop covered almost 500,000 acres, an area larger than all the coca fields in Latin America. From a modest 185 tons at the start of American intervention in 2001, Afghanistan now produced 8,200 tons of opium, a remarkable 53% of the country's GDP and 93% of global heroin supply." (Alfred W. McCoy, 2010)

Drug addiction is a chronic disease and denial is one of the hallmarks of all such ailments. The government, as well as private addiction treatment facilities, must provide incentives to drug abusers so that they are willing to be treated. Law enforcement agencies should refer drug addicts for treatment rather than sending them to jail where drugs are easily available. Most drug addiction treatment centres are located in big cities. The need of the hour is for treatment facilities to be established in small cities and towns. At the same time, incentives for professionals in this field should be provided. Currently, they lack training facilities.

Treatment at Your HOME

Now We Provide Treatment at Your Door Step at ISLAMABAD, RAWALPINDI and in the vicinity.

 

Ø   Drug Addiction (Detoxification & Counselling)

Ø   Acute Depression with / without Suicidal Tendency

Ø   Acute Psychotic Episodes (Schizophrenia, Mania)

Ø   Acute Stress Reaction

Ø   Acute Conversion Reactions

Ø   Deliberate Self Harm

    Other Relevant Neuropsychiatric Ailments in acute situations.

 Note: At home treatment is only available, where families are ready to cooperate and can facilitate the process. It would be easy, under supervision of a Consultant Psychiatrist at your door step and free of so feared stigma.
In case of acute suicidal attempt, kindly reach the nearest Medical Emergency Department of an established hospital.

Our Mission

WADA will not only offer detoxification, but will ensure a sustained lifelong recovery from addiction to Narcotics, Cannabis, Alcohol and other drugs. We will accomplish this through a commitment to treatment, education, psychosocial rehabilitation, research, public advocacy and shared learning with international organizations. We will also raise awareness, reduce stigma, treat and rehabilitate those suffering from Psychiatric Illnesses.

Our Vision

Ø All who will seek treatment and recovery from us will surely be benefited and
    the stigma of addiction will certainly be overcome.
ØOur Values treat the whole person not only addiction, as we take every individual differently according to his problems and requirements; then adjust and render services, which would suit the person best to give him a lifelong recovery free of drugs and full of mental harmony and serenity.

Ø Treat every person with dignity, respect and free of prejudice.
Ø Continue a commitment to the Twelve Step fellowship.
Ø To minimize the high rates of incidence and prevalence of Substance Abuse in Pakistan by raising awareness, developing socially adjustable treatment models, reducing stigma and providing a social support system.
ØToraise awareness, reduce stigma, treat and rehabilitate those suffering from Psychiatric Illnesses e.g. Schizophrenia, Bipolar Affective Disorder, Anxiety disorders, Major Depression and Personality Disorders, etc; either separately or co-morbid with substance abuse disorders.

We support these initiatives, as we believe in our work and God. By the grace of God our treatment works and we can surely make a difference in the lives of individuals, families and entire communities. We just expect from all of you to support yourselves, those who are suffering and those who are sincerely working against drug abuse and are extremely motivated to make things better in the domains of drug addiction and mental illnesses.

Frequently Asked Questions

Nearly all addicted individuals believe at the outset that they can stop using drugs on their own, and most try to stop without treatment. Although some people are successful, many attempts result in failure to achieve long-term abstinence. Research has shown that long-term drug abuse results in changes in the brain that persist long after a person stops using drugs. These drug-induced changes in brain function can have many behavioral consequences, including an inability to exert control over the impulse to use drugs despite adverse consequences—the defining characteristic of addiction. 

1. Why do drug addicted persons keep using drugs?

Understanding that addiction has such a fundamental biological component may help explain the difficulty of achieving and maintaining abstinence without treatment. Psychological stress from work, family problems, psychiatric illness, pain associated with medical problems, social cues (such as meeting individuals from one’s drug using past), or environmental cues (such as encountering streets, objects, or even smells associated with drug abuse) can trigger intense cravings without the individual even being consciously aware of the triggering event. Any one of these factors can hinder attainment of sustained abstinence and make relapse more likely. Nevertheless, research indicates that active participation in treatment is an essential component for good outcomes and can benefit even the most severely addicted individuals.

2.    What is drug addiction treatment?

Drug treatment is intended to help addicted individuals stop compulsive drug seeking and use. Treatment can occur in a variety of settings, in many different forms, and for different lengths of time. Because drug addiction is typically a chronic disorder characterized by occasional relapses, a short-term, one-time treatment is usually not sufficient. For many, treatment is a long-term process that involves multiple interventions and regular monitoring. There are a variety of evidence-based approaches to treating addiction.

Drug treatment can include behavioral therapy (such as individual or group counseling, cognitive therapy, or contingency management), medications, or their combination. The specific type of treatment or combination of treatments will vary depending on the patient’s individual needs and, often, on the types of drugs they use. The severity of addiction and previous efforts to stop using drugs can also influence a treatment approach. Finally, people who are addicted to drugs often suffer from other health (including other mental health), occupational, legal, familial, and social problems that should be addressed concurrently. The best programs provide a combination of therapies and other services to meet an individual patient’s needs. Specific needs may relate to age, race, culture, sexual orientation, gender, pregnancy, other drug use, comorbid conditions (e.g., depression, HIV), parenting, housing, and employment, as well as physical and sexual abuse history. Drug addiction treatment can include medications, behavioral therapies, or their combination. Treatment medications, such as methadone, buprenorphine, and naltrexone, are available for individuals addicted to opioids, while nicotine preparations (patches, gum, lozenges, and nasal spray) and the medications varenicline and bupropion are available for individuals addicted to tobacco. Disulfiram, acamprosate, naltrexone, and topiramate are medications used for treating alcohol dependence, which commonly co-occurs with other drug addictions. In fact, most people with severe addiction are polydrug users and require treatment for all substances abused. Even combined alcohol and tobacco use has proven amenable to concurrent treatment for both substances. Psychoactive medications, such as antidepressants, antianxiety agents, mood stabilizers, and antipsychotic medications, may be critical for treatment success when patients have co-occurring mental disorders, such as depression, anxiety disorders (including post-traumatic stress disorder), bipolar disorder, or schizophrenia.

Behavioral therapies can help motivate people to participate in drug treatment; offer strategies for coping with drug cravings; teach ways to avoid drugs and prevent relapse; and help individuals deal with relapse if it occurs. Behavioral therapies can also help people improve communication, relationship, and parenting skills, as well as family dynamics. Many treatment programs employ both individual and group therapies. Group therapy can provide social reinforcement and help enforce behavioral contingencies that promote abstinence and a non-drugusing lifestyle. Some of the more established behavioral treatments, such as contingency management and cognitive-behavioral therapy, are also being adapted for group settings to improve efficiency and cost-effectiveness. However, particularly in adolescents, there can also be a danger of iatrogenic, or inadvertent, effects of group treatment; thus, trained counselors should be aware and monitor for such effects. Because they work on different aspects of addiction, combinations of behavioral therapies and medications (when available) generally appear to be more effective than either approach used alone. Treatment for drug abuse and addiction is delivered in many different settings using a variety of behavioral and pharmacological approaches.

3.    How effective is drug addiction treatment?

In addition to stopping drug abuse, the goal of treatment is to return people to productive functioning in the family, workplace, and community. According to research that tracks individuals in treatment over extended periods, most people who get into and remain in treatment stop using drugs, decrease their criminal activity, and improve their occupational, social, and psychological functioning.

For example, methadone treatment has been shown to increase participation in behavioral therapy and decrease both drug use and criminal behavior. However, individual treatment outcomes depend on the extent and nature of the patient’s problems, the appropriateness of treatment and related services used to address those problems, and the quality of interaction between the patient and his or her treatment providers.

Comparison of Relapse Rates

Between Drug Addiction and

Other Chronic Illnesses

DRUG ADDICTION

30 to 50%

TYPE I DIABETES

40 to 60%

HYPERTENSION

50 to 70%

ASTHMA

50 to 70%

Relapse rates for addiction resemble those of other chronic diseases such as diabetes, hypertension, and asthma.

Like other chronic diseases, addiction can be managed successfully. Treatment enables people to counteract addiction’s powerful disruptive effects on the brain and behavior and to regain control of their lives. The chronic nature of the disease means that relapsing to drug abuse is not only possible but also likely, with relapse rates similar to those for other well-characterized chronic medical illnesses—such as diabetes, hypertension, and asthma that also have both physiological and behavioral components. Unfortunately, when relapse occurs many deem treatment a failure. This is not the case: successful treatment for addiction typically requires continual evaluation and modification as appropriate, similar to the approach taken for other chronic diseases. For example, when a patient is receiving active treatment for hypertension and symptoms decrease, treatment is deemed successful, even though symptoms may recur when treatment is discontinued. For the addicted patient, lapses to drug abuse do not indicate failure—rather, they signify that treatment needs to be reinstated or adjusted, or that alternate treatment is needed.

4. How can families and friends make a difference in the life of someone needing treatment?

Family and friends can play critical roles in motivating individuals with drug problems to enter and stay in treatment. Family therapy can also be important, especially for adolescents. Involvement of a family member or significant other in an individual’s treatment program can strengthen and extend treatment benefits.

5.    What role can the criminal justice system play in addressing drug addiction?

Research has demonstrated that treatment for drug-addicted offenders during and after incarceration can have a significant effect on future drug use, criminal behavior, and social functioning. The case for integrating drug addiction treatment approaches with the criminal justice system is compelling. Combining prison- and community based treatment for addicted offenders reduces the risk of both recidivism to drug-related criminal behavior and relapse to drug use, which, in turn, nets huge savings in societal costs. One study found that prisoners who participated in a therapeutic treatment program in the

Delaware State prison system and continued to receive treatment in a work release program after prison were 70 percent less likely than nonparticipants to return to drug use and incur re-arrest.

Individuals who enter treatment under legal pressure have outcomes as favorable as those who enter treatment voluntarily. The majority of offenders involved with the criminal justice system are not in prison but are under community supervision. For those with known drug problems, drug addiction treatment may be recommended or mandated as a condition of probation. Research has demonstrated that individuals who enter treatment under legal pressure have outcomes as favorable as those who enter treatment voluntarily.

The criminal justice system refers drug offenders into treatment through a variety of mechanisms, such as diverting nonviolent offenders to treatment; stipulating treatment as a condition of incarceration, probation, or pretrial release; and convening specialized courts, or drug courts, that handle drug offense cases. These courts mandate and arrange for treatment as an alternative to incarceration, actively monitor progress in treatment, and arrange for other services for drug-involved offenders.

Treating Drug Addiction

Drug Addiction is a kind of Mental Illness and is mostly co-morbid with other Psychiatric Illnesses. WADA follows following Principles and Treatment Modalities in its endeavor to work against drug abuse and co-morbid mental illnesses for a better community comprising of healthy and productive individuals.

Principles of Effective Treatment

Addiction is a complex but treatable disease that affects brain function and behavior. Drugs of abuse alter the brain’s structure and function, resulting in changes that persist long after drug use has ceased. This may explain why drug abusers are at risk for relapse even after long periods of abstinence and despite the potentially devastating consequences.

• No single treatment is appropriate for everyone. Matching treatment settings, interventions, and services to an individual’s particular problems and needs is critical to his or her ultimate success in returning to productive functioning in the family, workplace, and society.
• Treatment needs to be readily available. Because drug-addicted individuals may be uncertain about entering treatment, taking advantage of available services the moment people are ready for treatment is critical. Potential patients can be lost if treatment is not immediately available or readily accessible. As with other chronic diseases, the earlier treatment is offered in the disease process, the greater the likelihood of positive outcomes.
• Effective treatment attends to multiple needs of the individual, not just his or her drug abuse. To be effective, treatment must address the individual’s drug abuse and any associated medical, psychological, social, vocational, and legal problems. It is also important that treatment be appropriate to the individual’s age, gender, ethnicity, and culture.
• Remaining in treatment for an adequate period of time is critical. The appropriate duration for an individual depends on the type and degree of his or her problems and needs. Research indicates that most addicted individuals need at least 3 months in treatment to significantly reduce or stop their drug use and that the best outcomes occur with longer durations of treatment. Recovery from drug addiction is a long-term process and frequently requires multiple episodes of treatment. As with other chronic illnesses, relapses to drug abuse can occur and should signal a need for treatment to be reinstated or adjusted. Because individuals often leave treatment prematurely, programs should include strategies to engage and keep patients in treatment.
• Counseling—individual and/or group— and other behavioral therapies are the most commonly used forms of drug abuse treatment. Behavioral therapies vary in their focus and may involve addressing a patient’s motivation to change, providing incentives for abstinence, building skills to resist drug use, replacing drug-using activities with constructive and rewarding activities, improving problem solving skills, and facilitating better interpersonal relationships. Also, participation in group therapy and other peer support programs during and following treatment can help maintain abstinence.
• Medications are an important element of treatment for many patients, especially when combined with counseling and other behavioral therapies. For example, methadone and buprenorphine are effective in helping individuals addicted to heroin or other opioids stabilize their lives and reduce their illicit drug use. Naltrexone is also an effective medication for some opioid-addicted individuals and some patients with alcohol dependence. Other medications for alcohol dependence include Acamprosate, disulfiram, and topiramate. For persons addicted to nicotine, a nicotine replacement product (such as patches, gum, or lozenges) or an oral medication (such as bupropion or varenicline) can be an effective component of treatment when part of a comprehensive behavioral treatment program.
• An individual’s treatment and services plan must be assessed continually and modified as necessary to ensure that it meets his or her changing needs. A patient may require varying combinations of services and treatment components during the course of treatment and recovery. In addition to counseling or psychotherapy, a patient may require medication, medical services, family therapy, parenting instruction, vocational rehabilitation, and/or social and legal services. For many patients, a continuing care approach provides the best results, with the treatment intensity varying according to a person’s changing needs.
• Many drug-addicted individuals also have other mental disorders. Because drug abuse and addiction—both of which are mental disorders—often co-occur with other mental illnesses, patients presenting with one condition should be assessed for the other(s). And when these problems co-occur, treatment should address both (or all), including the use of medications as appropriate.
• Medically assisted detoxification is only the first stage of addiction treatment and by itself does little to change long-term drug abuse. Although medically assisted detoxification can safely manage the acute physical symptoms of withdrawal and, for some, can pave the way for effective long-term addiction treatment, detoxification alone is rarely sufficient to help addicted individuals achieve long-term abstinence. Thus, patients should be encouraged to continue drug treatment following detoxification. Motivational enhancement and incentive strategies, begun at initial patient intake, can improve treatment engagement.
• Treatment does not need to be voluntary to be effective. Sanctions or enticements from family, employment settings, and/or the criminal justice system can significantly increase treatment entry, retention rates, and the ultimate success of drug treatment interventions.
• Drug use during treatment must be monitored continuously, as lapses during treatment do occur. Knowing their drug use is being monitored can be a powerful incentive for patients and can help them withstand urges to use drugs. Monitoring also provides an early indication of a return to drug use, signaling a possible need to adjust an individual’s treatment plan to better meet his or her needs.
• Treatment programs should assess patients for the presence of HIV/ AIDS, hepatitis B and C, tuberculosis, and other infectious diseases as well as provide targeted risk-reduction counseling to help patients modify or change behaviors that place them at risk of contracting or spreading infectious diseases.